Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-25 @ 7:17 PM
Study NCT ID:
NCT00091832
Status:
COMPLETED
Last Update Posted:
2014-01-28
First Post:
2004-09-17
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2005-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-17
First Submit QC Date:
None
Study First Post Date:
2004-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-12-09
Results First Submit QC Date:
None
Results First Post Date:
2011-01-07
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2009-11-25
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2013-12-20
Last Update Post Date:
2014-01-28
Last Update Post Date Type:
ESTIMATED